Delivery Order SPE2DB22D1017-SPE2DB25FG7RM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,907.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025. This competitively awarded, firm fixed price delivery order is scheduled for completion by July 21, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract involves no set-aside designation and is issued as a child order under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a ceiling value of $2,344.84. This firm fixed-price delivery order, which must be completed by July 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award is unclassified as a set-aside contract, indicating it was competitively awarded....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,342.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on July 21, 2025, with completion targeted for July 22, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency awarded a $2,044.08 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL quantity). The contract, which is not set-aside, is scheduled for completion by June 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,345.87 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Trulicity 3 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for completion by July 21, 2025, with performance taking place at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,593.10 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units). The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $4,753.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pens. This $4,118.70 contract has a completion date of February 15, 2024 and was awarded on February 14, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor and will deliver the pharmaceuticals to the DLA Troop Support Medical facilities in Conshohocken,...
- This is a $11,496.24 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a diabetes medication, with a performance period through June 17, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded contract with no set-aside designation. The products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters and primary operations center....
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG7RMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,746.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes management medication. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, reflects a firm fixed-price contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed the delivery order from its corporate office location. This delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications for diabetes management, neurological conditions, pain management, and other therapeutic domains. The prime vendor arrangement facilitates deliveries to multiple government healthcare customers, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's competitively awarded contract portfolio demonstrates its capability to fulfill federal medical procurement requirements across varying transaction values, supporting the DLA's critical mission to maintain pharmaceutical supply chain readiness for the Department of Defense and other federal health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/18/25 |